Tin Kyaw Kyaw Aung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tin Kyaw Kyaw Aung has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Bhaskar Dasgupta
Rheumatology, Anglia Ruskin University, Chelmsford, UK
2 shared publications - Faidra Laskou
MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK
2 shared publications - Saptarshi Banerjee
Department of Radiotherapy, Medical College and Hospital, Kolkata, West Bengal, India
2 shared publications - Amin Ali
Division of Medicine, Sengkang General Hospital, Singapore
1 shared publication - Bingfeng Matthew Chuah
Department of Endocrinology, Sengkang General Hospital , Singapore 554886 , Singapore
1 shared publication - Cynthia S. Crowson
Division of Rheumatology Mayo Clinic Rochester Minnesota
1 shared publication
Latest Publications
- 1 November 2021
- Published by Elsevier in The American Journal of Medicine
- Vol. 134 (11) , 1357-1361
More Than Meets the Eye: A Patient with Hand Swelling and Newly Diagnosed Diabetes Mellitus
- 1 November 2021
- Published by Elsevier in The American Journal of Medicine
- Vol. 134 (11) , 1357-1361
More Than Meets the Eye: A Patient with Hand Swelling and Newly Diagnosed Diabetes Mellitus
- 1 April 2021
- Published by Elsevier in The American Journal of Medicine
- Vol. 134 (4) , e285-e286
Painless Aortic Dissection Presenting with Isolated Dysphagia
- 1 April 2021
- Published by Elsevier in The American Journal of Medicine
- Vol. 134 (4) , e285-e286
Painless Aortic Dissection Presenting with Isolated Dysphagia
- Open Access
- 1 June 2020
- Published by Elsevier in Osteoporosis and Sarcopenia
- Vol. 6 (2) , 53-58
Comparison of the Osteoporosis Self-Assessment Tool for Asians and the fracture risk assessment tool - FRAX to identify densitometric defined osteoporosis: A discriminatory value analysis in a multi-ethnic female population in Southeast Asia
- 1 June 2020
- Published by Elsevier in Osteoporosis and Sarcopenia
- Vol. 6 (2) , 53-58
Open AccessComparison of the Osteoporosis Self-Assessment Tool for Asians and the fracture risk assessment tool - FRAX to identify densitometric defined osteoporosis: A discriminatory value analysis in a multi-ethnic female population in Southeast Asia
- Open Access
- 1 June 2018
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 77 (Suppl 2) , 434
THU0443 A probability score from a fast track clinic to aid the management of suspected giant cell arteritis
Background Diagnosis of Giant Cell Arteritis(GCA) is difficult since its manifestations are protean1. Under-diagnosis is associated with ischaemic complications whereas over diagnosis is associated with inappropriate glucocorticoids (GC)2.GCA is diagnosed by different specialties, including family physicians, who would benefit from a clinical prediction score.A fast track pathway also requires clinical triage in terms of probability of disease. We evaluated all referred patients (08/16–08/17) to develop a pre-test probability score(PTBS) to support a diagnostic pathway and decision-making. Methods The PTBS was generated from long standing clinical experience. Information collected at initial assessment was given varying positive weightage. This included baseline demographics (age-gender), symptomatology at presentation(onset, headache and scalp tenderness, ischaemic symptoms, constitutional symptoms, polymyalgia),C-Reactive protein(CRP) and examination findings(ischaemic ophthalmic complications, temporal artery abnormalities, extra-cranial abnormalities, cranial nerve palsies). Negative weightage was given for competing diagnoses (infection, cancer, head and neck pathology, systemic rheumatological diseases). The PTBS was compared with the final diagnosis as GCA or non-GCA 6 months after the initial assessment. Analysis was performed in Stata SE, version 13.1. Results 122 PTBS were collected of which CRP was missing in 1 case which was excluded from the analysis.23 had a final diagnosis of GCA at 6 months follow up. The rest consist our control group(99 patients). The area under the ROC curve for the 121 cases was 0.953 (figure 1). Using the bootstrap method gave an estimated area under the ROC curve (95% confidence interval) of 0.953 (0.911, 0.994). At the point of inflection, corresponding to a cut point of 9.5, sensitivity was 95.7%, and specificity was 86.7%;the likelihood ratio for a positive test was 7.2 and the likelihood ratio for a negative test, 0.050. At this cut point, 88.4% cases were correctly classified. Conclusions This single centre retrospective study suggests that PTBS is a useful standardised assessment tool for rating pre-test probability for GCA with high levels of sensitivity and specificity. PTBS may reduce variation in clinical assessment and aid decision making.A patient with low probability score(References [1] Murchison AP, et al. Validity of the American College of Rheumatology Criteria for the Diagnosis of Giant Cell Arteritis.Am J Ophthalmol2012Oct;154(4):722–9. [2] Elsideeg S, et al. SAT0293 Association between Clinical Presentation and Blindness in Gca and Effects of Gca-Related Visual Loss on Morbidity, Mortality and Quality of Life. Ann Rheum Dis2014Jun;73(Suppl 2):699.1–699. Disclosure of Interest None declared
- 1 June 2018
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 77 (Suppl 2) , 434
Open AccessTHU0443 A probability score from a fast track clinic to aid the management of suspected giant cell arteritis
Background Diagnosis of Giant Cell Arteritis(GCA) is difficult since its manifestations are protean1. Under-diagnosis is associated with ischaemic complications whereas over diagnosis is associated with inappropriate glucocorticoids (GC)2.GCA is diagnosed by different specialties, including family physicians, who would benefit from a clinical prediction score.A fast track pathway also requires clinical triage in terms of probability of disease. We evaluated all referred patients (08/16–08/17) to develop a pre-test probability score(PTBS) to support a diagnostic pathway and decision-making. Methods The PTBS was generated from long standing clinical experience. Information collected at initial assessment was given varying positive weightage. This included baseline demographics (age-gender), symptomatology at presentation(onset, headache and scalp tenderness, ischaemic symptoms, constitutional symptoms, polymyalgia),C-Reactive protein(CRP) and examination findings(ischaemic ophthalmic complications, temporal artery abnormalities, extra-cranial abnormalities, cranial nerve palsies). Negative weightage was given for competing diagnoses (infection, cancer, head and neck pathology, systemic rheumatological diseases). The PTBS was compared with the final diagnosis as GCA or non-GCA 6 months after the initial assessment. Analysis was performed in Stata SE, version 13.1. Results 122 PTBS were collected of which CRP was missing in 1 case which was excluded from the analysis.23 had a final diagnosis of GCA at 6 months follow up. The rest consist our control group(99 patients). The area under the ROC curve for the 121 cases was 0.953 (figure 1). Using the bootstrap method gave an estimated area under the ROC curve (95% confidence interval) of 0.953 (0.911, 0.994). At the point of inflection, corresponding to a cut point of 9.5, sensitivity was 95.7%, and specificity was 86.7%;the likelihood ratio for a positive test was 7.2 and the likelihood ratio for a negative test, 0.050. At this cut point, 88.4% cases were correctly classified. Conclusions This single centre retrospective study suggests that PTBS is a useful standardised assessment tool for rating pre-test probability for GCA with high levels of sensitivity and specificity. PTBS may reduce variation in clinical assessment and aid decision making.A patient with low probability score(References [1] Murchison AP, et al. Validity of the American College of Rheumatology Criteria for the Diagnosis of Giant Cell Arteritis.Am J Ophthalmol2012Oct;154(4):722–9. [2] Elsideeg S, et al. SAT0293 Association between Clinical Presentation and Blindness in Gca and Effects of Gca-Related Visual Loss on Morbidity, Mortality and Quality of Life. Ann Rheum Dis2014Jun;73(Suppl 2):699.1–699. Disclosure of Interest None declared
- Open Access
- 1 June 2018
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 77 (Suppl 2) , 774-775
FRI0494 Spectrum of visual involvement in giant cell arteritis
Background The dreaded complication of giant cell arteritis (GCA), irreversible sight loss (SL), is present in 15%–25% of patients at diagnosis. This is likely due to delayed presentation, recognition and treatment. Fast track pathways for urgent assessment of suspected GCA reduce SL with associated cost savings. Information regarding the burden of SL in GCA is required to guide health strategy and has been explored in this UK wide study. Methods This is a prospective observational multi-centre study of visual involvement attributable to GCA. Demographic, disease features and treatment information was collected on all patients with new or relapsing GCA with or without visual symptoms (VS) or SL.SL was defined as symptomatic loss of acuity, field of vision or diplopia ascribable to ischaemic complications of GCA. Patients with transient VS were not considered to have SL. Analyses were performed using chi-squared and rank sum tests. Results Patients were predominantly female (274/388) and Caucasian; 3 non-Caucasian(Asian British, Black/Afro-Caribbean and Turkish).VS were present in 135/388 patients (35%) from 19 UK sites. Of patients with VS, these were transient or intermittent SL (n=9,7%), diplopia (n=33,24%), blurred vision (n=17,13%), flashing lights (n=4,3%) and eye pain (n=7,5%). Transient or permanent loss of acuity occurred in 92 patients (48 anterior ischaemic optic neuropathy [AION], 6 central retinal artery occlusion [CRAO],1 posterior ischaemic optic neuropathy, all attributed to GCA);1 hemispheric retinal vein occlusion, 1 branch retinal artery occlusion, 1 peri-papillary haemorrhage, 1 vitelliform dystrophy macula.8 had oculomotor nerve palsies(NP)(1 bilateral 3rd,1 bilateral 6th and 6 unilateral 3rd or 6th NP). Patients with VS were older than those without(mean ±SD age 75.9±9.3 and 73.5±8.5 respectively, pConclusions VS often leading to SL in GCA requires urgent management. Patients with VS were older, without ‘typical symptoms’ such as headache and polymyalgia but more likely to have ischaemic symptoms such as jaw and tongue pain and hypertension. Recognition of VS associated features should be embodied in public and professional awareness programs to prevent permanent SL in GCA. Disclosure of Interest None declared
- 1 June 2018
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 77 (Suppl 2) , 774-775
Open AccessFRI0494 Spectrum of visual involvement in giant cell arteritis
Background The dreaded complication of giant cell arteritis (GCA), irreversible sight loss (SL), is present in 15%–25% of patients at diagnosis. This is likely due to delayed presentation, recognition and treatment. Fast track pathways for urgent assessment of suspected GCA reduce SL with associated cost savings. Information regarding the burden of SL in GCA is required to guide health strategy and has been explored in this UK wide study. Methods This is a prospective observational multi-centre study of visual involvement attributable to GCA. Demographic, disease features and treatment information was collected on all patients with new or relapsing GCA with or without visual symptoms (VS) or SL.SL was defined as symptomatic loss of acuity, field of vision or diplopia ascribable to ischaemic complications of GCA. Patients with transient VS were not considered to have SL. Analyses were performed using chi-squared and rank sum tests. Results Patients were predominantly female (274/388) and Caucasian; 3 non-Caucasian(Asian British, Black/Afro-Caribbean and Turkish).VS were present in 135/388 patients (35%) from 19 UK sites. Of patients with VS, these were transient or intermittent SL (n=9,7%), diplopia (n=33,24%), blurred vision (n=17,13%), flashing lights (n=4,3%) and eye pain (n=7,5%). Transient or permanent loss of acuity occurred in 92 patients (48 anterior ischaemic optic neuropathy [AION], 6 central retinal artery occlusion [CRAO],1 posterior ischaemic optic neuropathy, all attributed to GCA);1 hemispheric retinal vein occlusion, 1 branch retinal artery occlusion, 1 peri-papillary haemorrhage, 1 vitelliform dystrophy macula.8 had oculomotor nerve palsies(NP)(1 bilateral 3rd,1 bilateral 6th and 6 unilateral 3rd or 6th NP). Patients with VS were older than those without(mean ±SD age 75.9±9.3 and 73.5±8.5 respectively, pConclusions VS often leading to SL in GCA requires urgent management. Patients with VS were older, without ‘typical symptoms’ such as headache and polymyalgia but more likely to have ischaemic symptoms such as jaw and tongue pain and hypertension. Recognition of VS associated features should be embodied in public and professional awareness programs to prevent permanent SL in GCA. Disclosure of Interest None declared